Telmisartan – 80 mg
23.00 €
Key Features
Aspect | Information |
---|---|
Brand | Tezeo |
Active Ingredient | Telmisartan |
Dosage | 80 mg |
Quantity | 30 tablets |
Half-Life | ~24 hours |
Use | Hypertension, vascular protection |
Stacks With | TRT, statins, CoQ10 |
Administration | Oral |
Water Retention | No |
Online Availability | Yes – ships to Germany |
Buy Telmisartan 80 mg Online in Germany – Tezeo Tablets for Hypertension
Tezeo 80 mg is a pharmaceutical-grade Telmisartan product used for high blood pressure management and cardiovascular protection. Manufactured by Zentiva, this 30-tablet pack is available exclusively online for customers in Germany.
Ideal for both clinical use and as part of a TRT or anabolic support protocol, Telmisartan helps control blood pressure and prevent vascular stress, especially in cycles where water retention or estrogenic compounds are involved.
Key Benefits
-
Manages essential hypertension effectively
-
Protects against stroke and heart complications
-
Long 24-hour control with once-daily dosing
-
Useful during bodybuilding cycles to manage pressure spikes
-
Non-diuretic approach to cardiovascular safety
How It Works
Telmisartan is an angiotensin II receptor antagonist (ARB) that blocks the hormone responsible for blood vessel constriction. This leads to relaxed arteries and more efficient blood flow, which reduces systolic and diastolic pressure.
For enhanced wellness during PED use, it is often taken throughout cycles to maintain safe cardiovascular performance.
Recommended Dosage
-
Standard Usage: 40–80 mg daily
-
During Cycle: 1 tablet per day in the morning
-
Can Be Combined With: CoQ10, vitamin K2, omega-3, low-dose aspirin
-
Monitor: Blood pressure weekly if using for non-medical reasons
⚠️ Warnings
-
Not for use during pregnancy
-
Do not combine with other ARBs or ACE inhibitors
-
Avoid excessive potassium supplements
-
Consult if using insulin or diabetic medication
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.